Strategies to detect and treat MSM with acute infection may be a powerful tool to control HIV epidemics
Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study
No increase in risk behaviour in people taking antiretroviral therapy, meta-analysis shows
First-line antiretroviral therapy has improved over time, meta-analysis shows
Intervention with cash lottery prizes cuts HIV infection by 39% in young women in Lesotho
Ambitious plans for treatment as prevention in Asia, but challenges remain
Dolutegravir superior to raltegravir for treatment-experienced people with HIV
Reduced efavirenz dose suppresses HIV as well as standard dose
Study supports WHO recommendations for second-line HIV therapy in resource-limited countries
Bangkok PrEP study finds PrEP efficacy is related to drug exposure
PrEP appears safe for use in conception, but may not be necessary if partner is taking treatment
First-ever community-randomised combination prevention trial produces modest drop in HIV incidence, big increase in testing in men
Two stem cell transplant recipients now controlling HIV off treatment
How can most-at-risk populations be encouraged to seek HIV testing?
Kick, kill, contain – researchers examine three possible steps in a cure for HIV
Starting treatment at a CD4 count above 500 reduces the HIV reservoir for people with long-term infection
Home visits during pregnancy increase number of male partners tested for HIV
